http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Chang-hao Piao,Chao Jiang,Hongtao Qiao,조종두,Sheng Lu 제어·로봇·시스템학회 2014 International Journal of Control, Automation, and Vol.12 No.6
A fixed switching frequency sliding mode (FSFSM) controller for two-stage DC-DC converter is proposed. Owing to the time-varying switched mode operation, the dynamic performance of two-stage converter becomes high order and non-linear. For designing the FSFSM controller, the state-space average model is made, and then the three conditions of sliding mode (SM) control, namely, hitting, existence and stability condition are analyzed. A conventional linear controller (Lag) for two-stage converter is designed as a comparison to validate the good robustness and dynamic response of the FSFSM controller. At last, a series of simulation and experimental results are presented to demonstrate the feasibility of the designed FSFSM controller.
Chunmei Li,ZhezheWang,Guisheng Li,ZhenhuaWang,Jianrong Yang,Yanshen Li,Hongtao Wang,Haizhu Jin,Junhua Qiao,Hongbo Wang,Jingwei Tian,Albert W. Lee,Yonglin Gao 고려인삼학회 2020 Journal of Ginseng Research Vol.44 No.2
Background: 20(S)-ginsenoside-Rg3 (C42H72O13), a natural triterpenoid saponin, is extracted from redginseng. The increasing use of 20(S)-ginsenoside Rg3 has raised product safety concerns. Methods: In acute toxicity, 20(S)-ginsenoside Rg3 was singly and orally administrated to Kunming miceand SpragueeDawley (SD) rats at the maximum doses of 1600 mg/kg and 800 mg/kg, respectively. In the26-week toxicity study, we used repeated oral administration of 20(S)-ginsenoside Rg3 in SD rats over 26weeks at doses of 0, 20, 60, or 180 mg/kg. Moreover, a 4-week recovery period was scheduled to observethe persistence, delayed occurrence, and reversibility of toxic effects. Results: The result of acute toxicity shows that oral administration of 20(S)-ginsenoside Rg3 to mice andrats did not induce mortality or toxicity up to 1600 and 800 mg/kg, respectively. During a 26-weekadministration period and a 4-week withdrawal period (recovery period), there were no significantdifferences in clinical signs, body weight, food consumption, urinalysis parameters, biochemical andhematological values, or histopathological findings. Conclusion: The mean oral lethal dose (LD50) of 20(S)-ginsenoside Rg3, in acute toxicity, is above 1600mg/kg and 800 mg/kg in mice and rats, respectively. In a repeated-dose 26-week oral toxicity study, theno-observed-adverse-effect level for female and male SD rats was 180 mg/kg.
Li, Chunmei,Wang, Zhezhe,Li, Guisheng,Wang, Zhenhua,Yang, Jianrong,Li, Yanshen,Wang, Hongtao,Jin, Haizhu,Qiao, Junhua,Wang, Hongbo,Tian, Jingwei,Lee, Albert W.,Gao, Yonglin The Korean Society of Ginseng 2020 Journal of Ginseng Research Vol.44 No.2
Background: 20(S)-ginsenoside-Rg3 (C<sub>42</sub>H<sub>72</sub>O<sub>13</sub>), a natural triterpenoid saponin, is extracted from red ginseng. The increasing use of 20(S)-ginsenoside Rg3 has raised product safety concerns. Methods: In acute toxicity, 20(S)-ginsenoside Rg3 was singly and orally administrated to Kunming mice and Sprague-Dawley (SD) rats at the maximum doses of 1600 mg/kg and 800 mg/kg, respectively. In the 26-week toxicity study, we used repeated oral administration of 20(S)-ginsenoside Rg3 in SD rats over 26 weeks at doses of 0, 20, 60, or 180 mg/kg. Moreover, a 4-week recovery period was scheduled to observe the persistence, delayed occurrence, and reversibility of toxic effects. Results: The result of acute toxicity shows that oral administration of 20(S)-ginsenoside Rg3 to mice and rats did not induce mortality or toxicity up to 1600 and 800 mg/kg, respectively. During a 26-week administration period and a 4-week withdrawal period (recovery period), there were no significant differences in clinical signs, body weight, food consumption, urinalysis parameters, biochemical and hematological values, or histopathological findings. Conclusion: The mean oral lethal dose (LD<sub>50</sub>) of 20(S)-ginsenoside Rg3, in acute toxicity, is above 1600 mg/kg and 800 mg/kg in mice and rats, respectively. In a repeated-dose 26-week oral toxicity study, the no-observed-adverse-effect level for female and male SD rats was 180 mg/kg.